Skip to search formSkip to main contentSkip to account menu

Hevac B

Known as: Hevac B Pasteur, Hevac-B, Hevac-B Pasteur 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Hepatitis B Surface Antigen VaccineHepatitis B Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Electrochemical switching fluorescence emission in rhodamine derivatives
2014
2014
Improved stability and efficacy of chitosan/pDNA complexes for gene delivery
Among polymeric polycations, chitosan has emerged as a powerful carrier for gene delivery. Only a few studies have focused on the… 
2006
2006
Effects of cyclothiazide on GluR 1 AMPA receptors
*Istituto Pasteur–Fondazione Cenci Bolognetti, Dipartimento di Fisiologia Umana e Farmacologia, Centro di Eccellenza BEMM… 
2003
2003
Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
1998
1998
The effect of live measles vaccines on serum vitamin A levels in healthy children
Abstract Objective: Serum retinol levels have been shown to be depressed during measles infection. This study aims to demonstrate… 
1997
1997
[Acute disseminated encephalomyelitis and meningococcal A and C vaccine: case report].
A 25-year-old women developed acute disseminated post-vaccinal encephalomyelitis (ADEM) following vaccination with A plus C… 
1996
1996
Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
Sera from subjects vaccinated with the Pasteur Merieux (PM) inactivated hepatitis A vaccine (AVAXIM) have been analysed in order… 
1992
1992
Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.
1991
1991
Formulation of a flowable liquid concentrate of Bacillus thuringiensis serotype H-14 spores and crystals as mosquito larvicide.
Bacillus thuringiensis serotype H-14 spores and crystals, produced in 51 fermenters, were centrifuged and resuspended in… 
1990
1990
Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure
The immune response after hepatitis B (HB) vaccine HEVAC B was studied in 33 children (mean age 10±4 years) with advanced renal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)